Copyright © 2015 - 2022 Lifecarenews.in
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Valo Therapeutics Announces First Patient Dosed with
HELSINKI, Finland, May 23, 2023 (GLOBE NEWSWIRE) -- Valo…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dosed
TILT Biotherapeutics Announces First Patient Dosed in Phase
HELSINKI, Finland, May 15, 2023 (GLOBE NEWSWIRE) -- TILT…
Y-mAbs Announces First Patient Dosed in Phase 1 Clinical
NEW YORK, April 05, 2023 (GLOBE NEWSWIRE) -- Y-mAbs…
Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8007, an Antibody-Drug…
GUANGZHOU, China--(BUSINESS WIRE)--#ADC--Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in a Phase 1 clinical study evaluating BAT8007, an antibody-drug conjugate…
First Wave BioPharma Announces Second Patient Dosed in
<!-- Name:DistributionId Value:8785886 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4570 -->…
Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8010, an Antibody Drug…
GUANGZHOU, China--(BUSINESS WIRE)--#ADC--Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in a Phase 1 clinical study evaluating BAT8010, an antibody-drug conjugate…
Cytovation announces first patient dosed in Phase 2a study
<!-- Name:DistributionId Value:1000782624 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4570 -->…
Heartseed and Novo Nordisk announce first patient dosed in
<!-- Name:DistributionId Value:1000781927 -->
<!-- Name:NewsArchiveTags Value:1491,5355 -->
<!-- Name:NewsArchiveOrgTags…
First Patient Dosed in Small Pharma’s Phase I Study
LONDON, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today…
Compass Therapeutics Announces First Patient Dosed in the
BOSTON, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”; Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human…